FTLP14 and ovarian serous cystadenocarcinoma: As shown in Fig. 2, KRT8P3, KRT8P45, and LDHAP5 predicted poor overall survival in ovarian serous cystadenocarcinoma (HR = 1.3, P = 0.046; HR = 1.3, P = 0.019; HR = 1.3, P = 0.03, respectively), FTLP14 predicted poor unfavorable prognosis in uterine corpus endometrioid carcinoma (HR = 2.6, P = 0.018) No other pseudogenes that were significantly correlated with poor prognosis in the four types of gynecological malignancies.